Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
99
100
Next >
How Viking Therapeutics Just Dealt A Blow To Eli Lilly's Obesity Triplet
October 24, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
LLY
VKTX
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care
October 24, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
BEAT
Different Classes of Medical Devices According to the FDA
October 24, 2024
Via
Syndication Cloud
Exposures
Product Safety
Corrective and Preventive Actions (CAPA) in Medical Device Cybersecurity
October 24, 2024
Via
Syndication Cloud
Topics
Data Breach
Exposures
Information Security
Product Safety
ELAN Deadline to Lead in Securities Fraud Lawsuit is December 6, 2024 - Contact Kaplan Fox & Kilsheimer LLP
October 18, 2024
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Product Safety
Lifesaving Portable, AI Augmented Cardiac Monitoring Technology Poised for Commercial Launch Under New Industry Leader: Heartbeam: Stock Symbol: BEAT
October 17, 2024
Via
PRLog
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Product Safety
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
October 23, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
HIMS
LLY
NVO
Penny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval Pathway
October 23, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
DBVT
FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
October 23, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
GSK
PFE
Annovis Bio Inc. (NYSE: ANVS) Receives FDA Clearance to Initiate Pivotal Phase 3 Alzheimer’s Studies, Paving the Way for NDA Filings
October 23, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
ANVS
$1.6M NIH Grant Awarded for the Development of the Kalm Patch
October 23, 2024
Via
Newsfile
Exposures
Product Safety
What's Going On With Sangamo Therapeutics Shares Tuesday?
October 22, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
SGMO
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
October 22, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
IRTC
From Student-Athlete, to General Contractor, to Chiropractor: Dr. Mark Chiungos Reflects on 25 Years of Serving The Chelmsford Community
October 22, 2024
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
Kaplan Fox & Kilsheimer LLP is Investigating Humacyte, Inc. (HUMA) for Potential Securities Law Violations
October 22, 2024
Via
NewMediaWire
Exposures
Product Safety
Tickers
HUMA
Kaplan Fox & Kilsheimer LLP is Investigating Humacyte, Inc. (HUMA) for Potential Securities Law Violations
October 22, 2024
Via
TheNewswire.com
Exposures
Product Safety
Tickers
HUMA
FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment
October 21, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BNTX
Why LENZ Therapeutics Stock Hit A New 52-Week High Today
October 21, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
LENZ
Humacyte Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
October 21, 2024
Via
NewMediaWire
Exposures
Product Safety
Tickers
HUMA
Humacyte Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
October 21, 2024
Via
TheNewswire.com
Exposures
Product Safety
Tickers
HUMA
Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against Humacyte, Inc. (HUMA)
October 19, 2024
Via
NewMediaWire
Exposures
Product Safety
Tickers
HUMA
Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against Humacyte, Inc. (HUMA)
October 19, 2024
Via
TheNewswire.com
Exposures
Product Safety
Tickers
HUMA
'Constantly stressed out': A woman's battle with excess cortisol
October 18, 2024
Via
Brandpoint
Topics
Product Recall
Exposures
Legal
Product Safety
What's Going On With TreeHouse Foods Stock Today?
October 18, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
ACTV
PSCC
THS
TechMediaBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Robert Eno as New CEO to Lead Next Phase of Growth and Innovation
October 17, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Product Safety
Tickers
BEAT
FDA Approves AbbVie's Parkinson's Treatment, Medicare Coverage Expected Next Year
October 17, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ABBV
Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug
October 17, 2024
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
Tickers
FOLD
TEVA
Deadline to Lead in Securities Fraud Lawsuit Against Elanco Animal Health Incorporated (ELAN) is December 6, 2024 - Contact Kaplan Fox & Kilsheimer LLP
October 17, 2024
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Receives First Payment from U.S. Defense Agency to Develop Broad-Spectrum Antiviral Agents
October 17, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
TNXP
AGC Biologics Seattle Achieves Approval for all 2024 Biologics License Applications from U.S. Food and Drug Administration, Concluding Pre-License Inspection
October 17, 2024
Via
News Direct
Exposures
Product Safety
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.